- Nuclear imaging devices are medical imaging equipment that use radioactive materials to diagnose the severity of disorders such as cardiovascular disease, cancer, gastrointestinal, endocrine, neurological, and other brain problems
- These non-invasive devices offer operational data at the molecular and cellular levels, allowing doctors to diagnose and assess medical issues
- U.S. is expected to dominate the nuclear imaging devices market with 34.3% due to its advanced healthcare infrastructure, high healthcare expenditure, and a substantial patient base requiring diagnostic imaging
- Canada is expected to be the fastest growing region in the nuclear imaging devices market during the forecast period due to increasing healthcare investments and technological advancements
- The single photon emission computed tomography (SPECT) segment is expected to dominate the market with a market share with 57.2% due to cost-effectiveness associated with SPECT equipment and procedures
